Clearmd

Clearmd was paid $1.20M by Medicaid between Jul 2021 and Apr 2023, across 9 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 45% of everything it billed.

33Billing provider infoCLEARMD
NEW YORK, NY 10003

33aNPI1376128090assigned 03/15/2021

33bProvider typeAnesthesiology Physician

28Total paid$1.20M

24GClaims34,433

24DCodes billed9

24AFirst – last monthJul 2021 – Apr 2023

Compared with peers

Next to other Anesthesiology Physician providers in New York

Rank by total paid#27 of 493

Median peer was paid$8K

This provider vs. median155×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	9,784	$258K
2022	23,700	$904K
2023	949	$35K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	45%	8,500	6,806	$540K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	19%	3,187	2,764	$228K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	16%	4,301	3,406	$189K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	15%	8,592	6,879	$174K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	2.4%	220	175	$28K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	1.6%	4,675	3,666	$19K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	309	259	$12K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	190	167	$6K
99072		<1%	4,459	3,577	$0.01

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRASHAN, ALI (CHIEF MEDICAL DIRECTOR)

Same official

Other billing entities under RASHAN, ALI

Full network →

Provider	Location	Paid
Ar Anesthesia LLC	New York, NY	$383K
Ali Rashan MD PLLC	New York, NY	$7K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.